The Proprietary Association of Great Britain (PAGB) has appointed GlaxoSmithKline’s (GSK) general manager of UK consumer healthcare Peter Harding as its new president.
Harding (pictured right) was previously VP of the PAGB, which represents manufacturers of over-the-counter (OTC) medicines and food supplements, and takes over from outgoing president Alex Pitt who has recently moved to a new role in Switzerland with Johnson & Johnson (J&J).
“I am delighted that Peter has been willing to take on the role of PAGB president and I look forward to working with him to deliver the programmes that will help stimulate the development of the OTC market in the UK,” said PAGB’s chief executive Sheila Kelly.
Harding joined GSK in 1997 and has previously served as general manager of its nutritional healthcare in the UK, working with GSK products including Ribena and Lucozade, before the nutritional business was merged with consumer healthcare.
“I’m very pleased to be taking up this role at a time when our industry continues to be faced with a lot of change,” said Harding.
“I’m very excited by the work programmes that we’ve put in place in 2012 and genuinely believe that these initiatives will contribute positively to driving innovation in our sector and growth in the market.“